Oncology Pharmaceutical Market in China: The Year of the Crab
This article was originally published in Start Up
Executive Summary
Cancer has overtaken respiratory and infectious diseases as the leading cause of mortality in both urban and rural China, creating an enormous demand for anti-cancer pharmaceuticals. According to "China Anti-Cancer Drug Market", a report distributed by FDC-Windhover Elsevier, the sales growth of anti-cancer drugs in China spiked from 11.1% in 2006 to 25.4% in 2007, at which point the market was worth $3.5 billion.